Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 116,529 | 80,010 | 317,823 | 273,595 | 219,035 |
| Depreciation Amortization | 54,458 | 27,732 | 114,130 | 84,496 | 56,634 |
| Income taxes - deferred | -19,363 | -9,004 | -37,048 | -26,479 | -16,992 |
| Accounts receivable | 3,498 | -9,965 | -49,034 | -93,848 | -102,791 |
| Other Working Capital | -120,213 | -100,935 | -24,638 | -51,463 | -127,992 |
| Other Operating Activity | 59,750 | 43,822 | 126,520 | 151,679 | 137,734 |
| Operating Cash Flow | $94,659 | $31,660 | $447,753 | $337,980 | $165,628 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 826 | 10,913 | N/A | N/A | N/A |
| PPE Investments | -26,053 | -14,452 | -38,089 | -26,254 | -12,522 |
| Net Acquisitions | -38,228 | N/A | -4,500 | N/A | N/A |
| Purchase Of Investment | -206,231 | -113,147 | -67,101 | -48,066 | -26,449 |
| Sale Of Investment | 34,162 | 2,001 | 64,785 | 44,372 | 23,214 |
| Purchase Sale Intangibles | -11,528 | -11,426 | N/A | N/A | N/A |
| Other Investing Activity | -11,528 | -11,426 | 0 | 0 | 0 |
| Investing Cash Flow | $-247,052 | $-126,111 | $-44,905 | $-29,948 | $-15,757 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 35,062 | 21,372 | 122,088 | 89,148 | 71,157 |
| Common Stock Repurchased | -120,486 | -35,573 | -245,864 | -149,764 | -110,775 |
| Dividend Paid | -50,681 | -25,283 | -89,172 | -66,883 | -44,574 |
| Other Financing Activity | -34,155 | -33,355 | -39,567 | -38,151 | -36,578 |
| Financing Cash Flow | $-170,260 | $-72,839 | $-252,515 | $-165,650 | $-120,770 |
| Exchange Rate Effect | -1,541 | -1,310 | 2,720 | 4,891 | 4,416 |
| Beginning Cash Position | 1,233,032 | 1,233,032 | 1,079,979 | 1,079,979 | 1,079,979 |
| End Cash Position | 908,838 | 1,064,432 | 1,233,032 | 1,227,252 | 1,113,496 |
| Net Cash Flow | $-324,194 | $-168,600 | $153,053 | $147,273 | $33,517 |
| Free Cash Flow | |||||
| Operating Cash Flow | 94,659 | 31,660 | 447,753 | 337,980 | 165,628 |
| Capital Expenditure | -26,053 | -14,452 | -54,454 | -42,619 | -28,887 |
| Free Cash Flow | 68,606 | 17,208 | 393,299 | 295,361 | 136,741 |